These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7557699

  • 1. [Resistance to activated protein C--a novel cause of thrombophilia].
    Cycowitz Z, Seligsohn U, Zivelin A, Eldor A.
    Harefuah; 1995 Jul; 129(1-2):1-5, 80. PubMed ID: 7557699
    [Abstract] [Full Text] [Related]

  • 2. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V, Leone G.
    Haematologica; 1995 Jul; 80(4):344-56. PubMed ID: 7590506
    [Abstract] [Full Text] [Related]

  • 3. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B.
    J Intern Med Suppl; 1997 Jul; 740():1-8. PubMed ID: 9350175
    [Abstract] [Full Text] [Related]

  • 4. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB, Sturk A.
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [Abstract] [Full Text] [Related]

  • 5. [Activated C protein resistance: laboratory study and prevalence of the defect in the Chilean population].
    Pereira J, Quiroga T, Goycoolea M, Muñoz B, Hidalgo P, Kaltwasser G, Mezzano D.
    Rev Med Chil; 1996 Jun; 124(6):663-8. PubMed ID: 9041721
    [Abstract] [Full Text] [Related]

  • 6. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN.
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [Abstract] [Full Text] [Related]

  • 7. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [Abstract] [Full Text] [Related]

  • 8. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [Abstract] [Full Text] [Related]

  • 9. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P, Scudeller A, Radossi P, Gavasso S, Girolami B, Tormene D, Girolami A.
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [Abstract] [Full Text] [Related]

  • 10. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B.
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [Abstract] [Full Text] [Related]

  • 11. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R, Ens GE.
    Clin Lab Sci; 1997 Jul; 10(4):219-22. PubMed ID: 10169621
    [Abstract] [Full Text] [Related]

  • 12. Homozygous APC-resistance combined with inherited type I protein S deficiency in a young boy with severe thrombotic disease.
    Zöller B, He X, Dahlbäck B.
    Thromb Haemost; 1995 May; 73(5):743-5. PubMed ID: 7482396
    [Abstract] [Full Text] [Related]

  • 13. Functional activated protein C resistance assays: correlation with factor V DNA analysis is better with RVVT-than APTT-based assays.
    Favaloro EJ, Mirochnik O, McDonald D.
    Br J Biomed Sci; 1999 May; 56(1):23-33. PubMed ID: 10492912
    [Abstract] [Full Text] [Related]

  • 14. [Resistance to activated protein C. The most common cause of familial thrombophilia].
    Larsen TB, Ravn HB, Lassen JF, Lund ED, Brandslund I.
    Ugeskr Laeger; 1996 Nov 11; 158(46):6584-8. PubMed ID: 8966822
    [Abstract] [Full Text] [Related]

  • 15. Thrombotic risk factors and oral contraception.
    Bokarewa MI, Falk G, Sten-Linder M, Egberg N, Blombäck M, Bremme K.
    J Lab Clin Med; 1995 Sep 11; 126(3):294-8. PubMed ID: 7665978
    [Abstract] [Full Text] [Related]

  • 16. Mutation in blood coagulation factor V associated with resistance to activated protein C.
    Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH.
    Nature; 1994 May 05; 369(6475):64-7. PubMed ID: 8164741
    [Abstract] [Full Text] [Related]

  • 17. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B, Svensson PJ, He X, Dahlbäck B.
    J Clin Invest; 1994 Dec 05; 94(6):2521-4. PubMed ID: 7989612
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of original and modified APC-resistance tests in unselected outpatients with clinically suspected thrombosis and in healthy controls.
    Svensson PJ, Zöller B, Dahlbäck B.
    Thromb Haemost; 1997 Feb 05; 77(2):332-5. PubMed ID: 9157592
    [Abstract] [Full Text] [Related]

  • 19. Resistance to activated protein C due to factor V R506Q mutation as a cause of venous thrombosis.
    Dahlbäck B.
    Rev Invest Clin; 1997 May 05; 49 Suppl 1():3-5. PubMed ID: 9291738
    [No Abstract] [Full Text] [Related]

  • 20. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ.
    Rev Invest Clin; 1996 May 05; 48(3):223-9. PubMed ID: 8966383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.